Walgreens has terminated its partnership with Blood-Testing Firm Theranos as regulators near a decision on whether to impose sanctions against the embattled Silicon Valley firm. Some officials at Walgreens have grown frustrated at not getting more details and documentation from Theranos after learning that tens of thousands of tests had been corrected.
This is a great example of an enterprise risk.
Please contact us at Contact@OxfordRMG.com or 410-472-6490 to speak with one of our captive research specialists!